Visipaque and depressed level of consciousness Patient Reports February 11, 2012

Visipaque Side Effects Report #4604135-X
Visipaque side effect was reported by a Pharmacist from on Mar 09, 2005. Male patient, 64 years of age, weighting 142.5 lb, was diagnosed with scan with contrast and was treated with Visipaque. After drug was administered, patient experienced the following side effects: apnoea, contrast media reaction, depressed level of consciousness, dyspnoea, flushing, hyperhidrosis, oedema, urticaria. Visipaque dosage: 50 ML IV OTO. During the same period patient was treated with TOPROL, LIPITOR, NORVASC, PLAVIX, SOSORBIDE, MUCOMYST, XYLOCAINE. Patient was hospitalized. Patient recovered.

Visipaque Side Effects Report #5698793-9
Visipaque side effect was reported by a Consumer or non-health professional from NORWAY on Apr 01, 2008. Female patient, 83 years of age, was diagnosed with renal cell carcinoma and was treated with Visipaque. After drug was administered, patient experienced the following side effects: cardiac arrest , depressed level of consciousness, heart rate decreased, loss of consciousness, malaise, retching, right ventricular failure, ventricular fibrillation. Visipaque dosage: 120 ML, SINGLE DOSE, I.V.. During the same period patient was treated with CARVEDILOL, LASIX. Patient died on 02/18/2008.

Visipaque Side Effects Report #5451912-1
Visipaque side effect was reported by a Health Professional from NORWAY on Aug 29, 2007. Male patient, 76 years of age, was diagnosed with neoplasm and was treated with Visipaque. After drug was administered, patient experienced the following side effects: amnestic disorder, convulsion, depressed level of consciousness, disorientation. Visipaque dosage: 70 ML, SINGLE DOSE, I.V.; SINGLE DOSE, I.V.. Patient recovered.

Visipaque Side Effects Report #5044346-5
Visipaque side effect was reported by a Health Professional from NORWAY on June 20, 2006. Female patient, 82 years of age, weighting 133.4 lb, was diagnosed with aortic stenosis and was treated with Visipaque. After drug was administered, patient experienced the following side effects: blood pressure increased, cardiac procedure complication, cerebral disorder, depressed level of consciousness. Visipaque dosage: 70 MG, SINGLE DOSE, I.A.. During the same period patient was treated with BUMETANIDE, ASPIRIN. Patient was hospitalized. Patient recovered.


Visipaque Side Effects Report #5605510-7
Visipaque side effect was reported by a Pharmacist from UNITED STATES on Jan 25, 2008. Female patient, 76 years of age, weighting 172.6 lb, was diagnosed with angiogram and was treated with Visipaque. After drug was administered, patient experienced the following side effects: contrast media reaction, depressed level of consciousness, mental status changes, renal failure acute, sepsis . Visipaque dosage: unknown. Patient died on 01/21/2008.

Visipaque Side Effects Report #5670082-8
Visipaque side effect was reported by a Consumer or non-health professional from NORWAY on Feb 26, 2008. Female patient, 83 years of age, was treated with Visipaque. After drug was administered, patient experienced the following side effects: cardiac arrest , depressed level of consciousness, malaise, vomiting. Visipaque dosage: 120 ML, SINGLE DOSE, I.V.. Patient died on 02/18/2008.

Visipaque Side Effects Report #5518616-8
Visipaque side effect was reported by a Health Professional from UNITED KINGDOM on Nov 01, 2007. Male patient, 62 years of age, was treated with Visipaque. After drug was administered, patient experienced the following side effects: ascites, cardiac failure, depressed level of consciousness, diabetes mellitus inadequate control, dialysis , fluid overload, miosis, multi-organ failure, nephropathy toxic. Visipaque dosage: 100 ML, SINGLE DOSE; SINGLE DOSE. During the same period patient was treated with GADOBUTROL, MEGLUMINE DIATRIZOATE, DIMEGLUMINE GADOPENTETATE, NALOXONE, IOPROMIDE, ALFACALCIDOL, AMLODIPINE. Patient was hospitalized. Patient died on 06/29/2005.